跳至主要内容
临床试验/NCT03120702
NCT03120702已完成不适用

Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population

Masimo Corporation2 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2013年7月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
128
试验地点
2
主要终点
Assess ability of Masimo SpHb sensor to demonstrate robust performance on various sensor application sites on neonates/infants

研究概览

简要总结

Assess ability of Masimo SpHb sensor to demonstrate robust performance on various sensor application sites on neonates/infants

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
— 至 16 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Male or female newborn infants of any gestational age requiring at least one (1) blood draw as part of their routine care.
  • Ages: Newborn infants less than 16 weeks postnatal age.
  • Weight: Range from 500 g to 10 kg.
  • Able to obtain written informed consent from parents or legal guardians

排除标准

  • Neonatal patients with abnormalities at the planned application sites that would interfere with transilluminating the foot or hand like unusual deformities of limbs, absence of feet, severe edema, localized infections, and other.

结局指标

主要结局

Assess ability of Masimo SpHb sensor to demonstrate robust performance on various sensor application sites on neonates/infants

时间窗: duration of surgery

To study the SpHb sensor in neonatal population.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Measurement of Total Hemoglobin by Pulse Oximetry in... | 临床试验